With the changing of demographics and shifting in attitudes, the onboarding process can never be a static situation and should be reviewed on an ongoing basis.

So where are we regarding timing before the flood gates open?

It has taken significant time to mend the relationship between pharmacy and the Ontario government since the 2010 pharmacy rallies at Queen’s Park in response to the elimination of professional allowances.

This was not a surprise as rumblings about Alberta taking the biosimilars plunge had been circulating for a few months.

While the changes to the PSP funding may not be a surprise to some given the growing lens of transparency within the industry, this revision could have significant implications.

Loss of exclusivity requires alot of effort with minimal financial reward for maintaining the life of a brand.

The Draft PMPRB Guidelines were released yesterday to explain how the amended Patented Medicines Regulations, that go into effect July 1, 2020 will be implemented.

Forteo (teriparatide, Lilly) is a biologic manufactured using recombinant DNA technology.

The ever-changing Canadian health care environment has forced the pharmaceutical industry to rethink external deployment.

Health Canada Officials provided an update today regarding the final Patented Medicines Regulations.